In This Issue
- BIO Salutes Charles Craig
- Morehouse School of Medicine, Office of Tech Transfer Has Outstanding First Year
- Education & Workforce Development Update: Bioscience Workforce Pipeline
- A Preview of the 2013 Georgia Legislative Session
New Member Highlight: Millennium Pharmaceuticals
The new Georgia Bio Newsletter
Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a first-in-class proteasome inhibitor, and has a robust clinical development pipeline of product candidates. Millennium Pharmaceuticals, Inc. was acquired by Takeda Pharmaceutical Company Ltd. in May, 2008. The Company’s research, development and commercialization activities are focused in oncology. Additional information about Millennium is available through its website, www.millennium.com.
Services to help you grow. Resources to help you thrive.
Your job is to manage your company’s resources wisely, and our job is to help your organization save money. Georgia Bio has partnered with the Biotechnology Industry Organization (BIO), the international association for the biotech industry, to offer GaBio members discounts and other benefits on products and services from industry-leading suppliers through BIO’s cost-savings program, BIO Business Solutions. This partnership provides GaBio members excellent discounts and special benefits on such products and services as laboratory products and equipment, clinical trials liability and other lines of commercial insurance policies, news distribution services, office supplies, computer and technology products and more.
GaBio's Purchasing Program will save your organization time and money
Many members have saved over the years, here are just some who take advantage and save! Learn more at www3.bio.org/bbs/georgia/.
- Abeome Corporation
- Aderans Research
- Alimera Sciences, Inc.
- C.R. Bard
- Geovax Labs, Inc.
- SJ Pharmaceuticals, LLC
Policy. Partnership. Action.
Georgia Bio is the state’s leading advocate for advancing the life sciences. Through advocacy work in Georgia and Washington D.C., Georgia Bio conducts programs, provides leadership and advocates for life science companies and university research essential to improving the health and economy of Georgia.
Sustaining the lobbying efforts of Georgia Bio requirse additional resources. Make a donation to help us educate our elected officials about the significance of the life sciences industry. Contact firstname.lastname@example.org for details.
BIO Salutes Charles Craig
By: Fritz Bittenbender, Vice President, Alliance Development and State Government Relations, BIO; Executive Director, CSBA
As a trade association, the Biotechnology Industry Organization (BIO) exists to advocate on behalf of our members - most of whom are small emerging companies. I am quite proud to say that our successful state and federal legislative efforts are most often aided by the strong and harmonious relationships we have built through the network of state bioscience-focused organizations collectively known as the Council of State Bioscience Associations (CSBA).
I am quite sure that I speak for the whole of the CSBA when I say that there are few individuals that better embody our common mission of promoting public understanding and support for the responsible development of the bioscience industry than Charlie Craig.
Not only has Charlie been tremendously instrumental to the growth of the bioscience industry in Georgia, but he played an active role in bringing the first BIO International Convention to the Southeast, when it was hosted in Atlanta in 2009. It should not be overlooked that he is also an alumnus of BIO, where he was our Director of Publications.
On behalf of BIO and the CSBA, I extend our warmest gratitude to our old friend, Charlie Craig for his years of service to this industry.
Morehouse School of Medicine, Office of Tech Transfer Has Outstanding First Year
By: Todd Stein, Morehouse School of Medicine
Morehouse School of Medicine (MSM) formally launched its Office of Translational Technologies (OTT) in July 2011 to manage and commercialize MSM’s growing patent portfolio and increase the level of contract procurement for clinical trials and research services. Today, OTT manages 27 issued patents and has more than 100 pending patent applications in the U.S. and around the world. To bring those technologies to market, OTT actively engages industry to partner and assist faculty start-up companies in licensing, developing and commercializing more than 30 products and services.
Over the past year, OTT has accomplished a great deal. OTT strengthened the school’s patent positions, added new staff and facilitated the execution of the first licensing deal in MSM’s history. Another highlight of OTT’s first year was its strong presence at the annual BIO International Convention that was held in Boston in June. MSM hosted a display booth, which was part of the Georgia Pavilion, a reception and participated in 41 partnering meetings with representatives from industry looking for new technologies to license. In addition, MSM’s Dean and Executive Vice President, Dr. Valerie Montgomery Rice, appeared on a panel of industry experts titled Patient-Centered Drug Development Strategy & Market Opportunity in Major Disease Categories.
OTT also plays a critical role in processing research related agreements on behalf of MSM, including Confidentiality Agreements, Material Transfer Agreements, MOUs, Inter-Institutional Agreements and Collaborative Research & Development Agreements. Those agreements are integral to MSM’s efforts to discover and develop new technologies. After all, the faster those agreements are executed, the quicker MSM’s researchers can explore new opportunities and innovate.
OTT strategically partnered with incumbent IT government contractors for subcontract awards. MSM has teaming agreements in place with several companies as their exclusive HBCU/MI and only academic partner for the Department of Treasury Internal Revenue Service Total Information Processing Support Services (DoT-IRS TIPSS4); the Navy Medicine Omnibus III; the Department of Health and Human Services Chief Information Officers Solutions and Partnering III (CIO-SP3); and the Department of Homeland Security Enterprise Acquisition Gateway for Leading Edge Solutions II (EAGLE II).
Looking forward, OTT plans to continue its efforts to translate discoveries aimed at reducing health disparities. As an institution, MSM is committed to improving access to care and is internationally known for its research in HIV/AIDS, cardiovascular disease, neuroscience and cancer. OTT will facilitate partnerships locally, nationally and internationally with other academic and medical institutions and corporations to help MSM faculty continue to innovate and turn their discoveries into the latest medical treatments.
Education & Workforce Development Update: Bioscience Workforce Pipeline
The mission of Georgia Bio’s Education and Workforce Development (EWD) program is to facilitate the alignment of the current and future workforce with the needs of Georgia’s life sciences industry. To accomplish this mission we are pleased to introduce the Bioscience Workforce Pipeline, an effort to promote a seamless life sciences career pathway from high school to 2- and 4-year institutions to the industry.
At the November meeting of Georgia Bio’s Board of Directors, members were surveyed to determine their support for components of the EWD’s Bioscience Workforce Pipeline program. They overwhelmingly endorsed the effort.
One of the components, the high school Visiting Scientist program is in full swing. The first industry scientists will be visiting 4 local high schools. The goal is to increase industry involvement in the high school biotechnology programs in order to provide students with real-world career exposure. By inspiring students, we aim to increase interest in science, technology, engineering and mathematics careers (STEM).
On December 7 Georgia Bio, in partnership with Atlanta Public Schools, Career Technical and Agriculture Education (CTAE) and Georgia Institute of Technology, held the first Biotech Cluster Meeting Workshop with 14 biotech teachers attending. The teachers were thrilled to have an industry representative talk to them about career trends and the importance of a strong STEM background. The workshop focused on recombinant DNA technology in the production of specific genetic constructs. The goal is to offer the workshop quarterly in order to strengthen teachers’ laboratory science skills.
The Bioscience Workforce Pipeline also includes work with post-secondary institutions to be responsive to workforce trends. If your company is involved in manufacturing you will find the University of Georgia’s Master of Biomanufacturing and Bioprocessing degree program a great asset to our region. The MBB program prepares students to work in medium to large businesses. With a bioexpression and fermentation facility, students work on professional equipment and complete a 400-hour industry internship. Find out more by visiting their website, http://biomanufacturing.uga.edu/index.php
In our ongoing effort to meet our member company’s current employee needs, Georgia Bio also is facilitating SOP training for the end of January 2013. If you would like information on this money saving initiative, please email Melissa Nikolic, Georgia Bio’s Director of Education and Workforce Development (email@example.com), to be added to our HR Network email list.
A Preview of the 2013
Georgia Legislative Session
By: James Seth Millican, Brock Clay Government and Public Affairs
As we look towards the 2013 legislative session, the state of relative change in which Georgia's political landscape has found itself for the past several years continues. The November elections ushered in over 30 new state legislators in the House and the Senate. Since that time, Senators John Bulloch (R - Oklochnee) and Chip Rogers (R - Woodstock) have resigned, setting off a domino effect of political jockeying for their seats.
In the meantime, the two year period of unrest that has existed in the Senate has come to a lull with Rogers, the former Majority Leader, leaving and Senator Tommie Williams (R - Lyons) stepping down as Senate President Pro-Tem. Taking over these leadership posts are allies of Lt. Gov. Casey Cagle. Senator David Shafer (R - Duluth) will serve as the President Pro-Tem, Senator Ronnie Chance (R - Tyrone) will serve as Majority Leader, and Senator Cecil Staton will continue as Majority Whip. The three have pledged their support for Cagle and his leadership in the Chamber.
The first year of the 2012-2013 biennium produced a high volume of legislation, although the primary focus will be on a few key issues:
- Filling the budget gap - Next year's budget is projected to have an approximately $300 million gap, a great deal of which will be in Medicaid. The Governor's office and the General Assembly will be faced with the challenge of filling that budget gap.
- Renewal of the controversial "hospital bed tax" - Several years ago, the General Assembly enacted a provider fee on hospitals that helped prevent Medicaid rate cuts by drawing down additional federal matching funds. That provider fee is scheduled to sunset unless renewed during the 2013 legislative session.
- Biosimilars and specialty tier drugs - The General Assembly will consider legislation dealing with both of these important issues.
- Personhood amendment - Legislation on personhood has already been filed.
While it's far too early to predict the outcome of any of these issues, Georgia Bio’s team will be engaged on a daily basis at the state Capitol to advocate on behalf of the bioscience industry's interests.
Georgia Bio Events
Small Group Dinner Series featuring CryoLife's VP of Research & Development
December 17, 2012
Georgia Bio Leaders Breakfast feauring Arbor's Ed Schutter
January 17, 2013
A Starry Night: Georgia Bio Awards Dinner & Education Fundraiser
January 24, 2013
Academic & Industry Intersection Conference
February 7, 2013
Biotech Showcase™ 2013
January 7–9, 2013
Freemind Group Non-Dilutive Funding Day
January 9, 2013
Canadian Healthcare & Licensing Association (CHLA) Winter Meeting 2013
February 6-8, 2013
Southeastern Medical Device Association (SEMDA) Conference
February 19–20, 2013
BioID Conference 2013: Biomedical Innovation & Development
Hosted by: Translational Research Institute for Biomedical Engineering and Science
February 21–22, 2013
Medical Devices Summit
February 28–March 1, 2013
BIO-Europe Spring 2013
March 11-13, 2013
Regenerative Medicine: Technologies Enabling Novel Therapies
17th Annual Hilton Head Workshop
March 20-23, 2013
Southeast Venture Philanthropy Summit
April 4, 2013
World Orphan Drug Congress USA 2013
April 9-11, 2013
2013 Awards Dinner & Education Fundraiser
January 24 | Fox Theatre
Did You Know...
Georgia Bio can help you recruit the talent needed to grow your organization?
1. Visit the online Career Center
2. Select Create an Employer Account
3. Post jobs today!
Your destination for exciting Life Science job opportunities is just a click away?
1. Visit the online Career Center
2. Select Search for Jobs
3. Post your resume today!
You can update your profile & view the members only directory at our members center?
1. Go to www.gabio.org and select Member Center, Update Profile from the top navigation panel
2. Sign in using your email address as the user name and password ('gabio' is a default password, or email firstname.lastname@example.org to request one)
3. Look for the View/Edit Profile link under your name on the page that opens
4. Here you can edit your profile, even load a picture
5. Scroll to the bottom left for the member directories
For the E-Chroncile Archives